Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Indian Rupee: Growth surprise supports range view against US Dollar – Commerzbank

Indian Rupee: Growth surprise supports range view against US Dollar – Commerzbank

FXStreetFXStreet2026/09/01 06:12

Commerzbank strategists argue that stronger-than-expected Q2 2026 Gross Domestic Product (GDP) at 7.8% yoy reinforces India’s relative growth advantage and reduces expectations of Reserve Bank of India (RBI) easing. They see upside risk to RBI’s FY2026-27 growth forecast, but warn about Oil, food and external demand risks. They maintain a near-term USD/INR range of 94–96, noting modest post-data Indian Rupee (INR) gains.

Rupee aided by robust GDP

"The economy expanded by a stronger-than-expected 7.8% yoy in Q2 2026 (Bloomberg consensus: 7.3%), while Q1 was revised up to 8.6% from 7.8% initially. The expansion was relatively broad-based, pointing to continued strength in both household demand and investment. It underscores the economy’s resilience despite the Middle East conflict and higher energy costs. "

"The strong report puts calendar H1 2026 growth at around 8.2% on a GDP basis and 8.4% on a GVA basis. More importantly, the 7.8% April-June print, the first quarter of FY2026-27, is comfortably above RBI’s 6.7% full-year growth forecast. Some moderation is likely as favourable base effects fade and higher energy costs weigh on real incomes and corporate margins."

"However, given the stronger-than-expected starting point and continued momentum in investment and manufacturing, there is now an upside risk to RBI’s FY2026-27 growth forecast, and the central bank could revise it higher at its 7 October meeting."

"We continue to look for a 94-96 range in the near term. A sustained INR appreciation would likely require a more durable decline in oil prices and an improvement in the external risk backdrop."

"For monetary policy, positive growth momentum further reduces the need for the RBI to provide additional accommodation and gives policymakers more room to focus on inflation risks. RBI is projecting FY2026-27 CPI inflation at 5.0%. It can remain in a wait-and-see mode for now, while a renewed spike in oil prices and evidence of second-round inflation effects remain the key risks."

"For INR, the growth surprise is modestly supportive as it reinforces India’s relative growth advantage, reduces expectations of monetary easing, and could encourage portfolio inflows. USD/INR eased around 0.2% to near 95.20 following the release."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11